At the news
? BEARISHIMPACT 5/10 PRESS-RELEASE filed Nov 9, 2026 at 16:01 ET
SIGA reported Q3 2026 revenue of $1.3M, down 50% YoY from $2.6M, and a net loss of $2.9M ($0.04 per share) vs. a $6.4M loss a year ago. The company highlighted a $15M Canadian procurement contract for oral TPOXX and the retirement of its Chief Scientific Officer, but the sharp revenue decline and lack of a new U.S. government contract weigh on the outlook.
- Q3 2026 total revenues $1.3M vs $2.6M in Q3 2025, a 50% decline
- Q3 2026 net loss $2.9M ($0.04 per share) vs $6.4M loss ($0.09) in Q3 2025
- Nine-month 2026 product sales $41.6M vs $85.8M in the prior year period
- Awarded $15M Canadian DND contract for oral TPOXX, with $9M firm commitments over 3 years
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access